Skip to main content

Candriam S.C.A.

Position in CLDX — Celldex Therapeutics, Inc.

CIK 1537014 STRASSEN, N4

Position in CLDX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$17,902,661
+$9,056,334 QoQ
Shares Held
481,125
+72.5% QoQ
Ownership
0.613%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#43
of 252 holders
Holding Since
Dec 2020
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CLDX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Candriam S.C.A. holds $2,107,868,027 across 75 Biotechnology names. CLDX ranks #41 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CLDX

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $17,902,661 481,125
2026-03-31 $8,846,327 278,888
2024-06-30 $11,751,008 317,509
2024-03-31 $13,325,852 317,509
2023-12-31 $12,592,406 317,509
2023-09-30 $8,875,447 322,509
2023-06-30 $18,678,770 550,509
2023-03-31 $21,426,413 595,509
2022-12-31 $21,772,846 488,509
2022-09-30 $11,764,287 418,509
2022-06-30 $7,839,806 290,794
2022-03-31 $9,451,002 277,481
2021-12-31 $14,962,219 387,221
2021-09-30 $9,730,185 180,222
2021-06-30 $13,365,466 399,685
2021-03-31 $7,089,263 344,139
2020-12-31 $6,029,315 344,139